StonvexLoading…
StonvexCore line items from COCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $609.78M | $516.01M | $493.61M | $427.79M |
Operating Income | $82.53M | $73.82M | $56.49M | $3.06M |
Net Income | $71.32M | $55.95M | $46.63M | $7.81M |
EPS (Diluted) | $1.19 | $0.94 | $0.79 | $0.14 |
Total Assets | $461.16M | $362.38M | $285.68M | $197.76M |
Total Liabilities | $129.62M | $103.56M | $83.25M | $56.66M |
Cash & Equivalents | $196.87M | $164.67M | $132.54M | $19.63M |
Free Cash Flow OCF − CapEx | $39.02M | $41.92M | $106.56M | $-11.92M |
Shares Outstanding | 57.08M | 56.96M | 56.90M | 56.02M |